Delphine is a senior pharma medical executive with broad European, US and global experience in the field of Medical Affairs, with a predominant focus on Oncology.
After practicing in academic hospitals in Paris, France, Delphine spent the last 15 years in roles of increasing responsibility at Roche, Genentech, Bristol-Myers Squibb and prior to joining SSI, at AstraZeneca, where she was the Medical Affairs SVP for the Oncology business unit. Through her different tenures, Delphine has led global and local medical functions with broad accountability from overall medical and non registrational evidence plans, to field teams, early access programs, Real World Evidence, Health Economics and Outcomes Research, publications, clinical operations, as well as external partnerships and alliances. She has accumulated considerable experience in organizational build and redesign, developing organizations with strong strategic and executional skills with the ability to directly and indirectly contribute to their company’s portfolio success, while driving demonstrable improvement in patients care and outcomes.
In her 25 years or hospital and pharma career, Delphine has accumulated deep knowledge and understanding of the various aspects of drug development & commercialization (including in territories such as Japan & China), of what is needed for successful interactions with health & reimbursement authorities, for co-development and commercialization partnerships and for scientific partnerships with private and public entities.
Delphine received her Medical degree from the Cochin School of Medicine in Paris, France, with a dual board certification in Hematology and Medical intensive care, as well as a Master degree and DEA in Immunology from the Rene Diderot University in Paris, France. She practiced at the Saint Louis Hospital and Gustave Roussy Cancer Institute in Paris, before starting her Pharma career at Roche.